This Week’s Industry News, RFK Jr. criticizes Gavi, Trump Pulls Federal Subscriptions, and More
July 1, 2025
Our latest news roundup reports on thimerosal elimination, subscription termination, depression alleviation, and more
4 min read
False
Advertisement
Latest
Unpacking the GLP-1 Gold Rush
June 30, 2025
We ask experts for their views on the GLP-1 market in this exclusive eBook.
1 min read
From Wall Street to Cell Therapy: Audrey Greenberg’s Journey
June 30, 2025
We sit down with Audrey Greenberg to discuss investment, cell therapy, and what to look for when hiring talent.
6 min read
Targeting the Untouchables: Covalent Peptides That Target Elusive Transcription Factors
June 27, 2025
Researchers have developed a new way to create covalent peptide inhibitors of transcription factors – proteins once considered “undruggable.”
8 min read
Biopharma Visionaries: From mRNA to Modular Manufacturing
June 27, 2025
Vaccines, mRNA, ADCS, and beyond! Check out our latest eBook where we speak with experts about the trends and challenges in biopharma drug development.
1 min read
Nut-Based Pharmaceuticals: From Food Waste to Functional Medicine
By Rob Coker
June 26, 2025
A look at how nut-derived pharmaceutical ingredients can deliver a sustainable, natural supply of peptides and more.
2 min read
This Week’s Biopharma News: Bayer, GSK, Eli Lilly, Novo Nordisk, and AZ – all positive.
June 26, 2025
Our latest news roundup reports on the Bayer-Tsinghua partnership expansion, GLP-1 diabetes treatments, and GSK EU acceptance of linerixibat.
3 min read
Spray-Drying for Success With mRNA
June 25, 2025
Why spray-drying could reduce supply chain costs, address infrastructure challenges, and pave the way for intranasal mRNA vaccine delivery.
5 min read
The Power List Personified: Getting to Know Kiran Mazumdar-Shaw
June 25, 2025
Learning more about the people behind the Power List 2025.
5 min read
This Week’s CGT News: Eli Lilly’s Verve takeover, and more
June 24, 2025
Our latest news roundup reports on Eli Lilly’s Verve takeover, novel CRISPR delivery research, a growing interest in CD5-based immunotherapy, and more
3 min read
